MARKET

SAGE

SAGE

SAGE
NASDAQ

Real-time Quotes | Nasdaq Last Sale

139.93
-4.90
-3.38%
After Hours: 141.08 +1.15 +0.82% 16:11 10/18 EDT
OPEN
144.01
PREV CLOSE
144.83
HIGH
144.88
LOW
139.03
VOLUME
390.17K
TURNOVER
--
52 WEEK HIGH
193.56
52 WEEK LOW
79.88
MARKET CAP
7.23B
P/E (TTM)
-11.0515
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of SAGE and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 19 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

SAGE News

  • Relmada Shares Hit 4-Year High As Depression Drug Aces Midstage Trial
  • Benzinga.5d ago
  • Why Did the Market Whack This IPO?
  • MotleyFool.com.6d ago
  • Moving Average Crossover Alert: Sage Therapeutics
  • Zacks.6d ago
  • These battered biotech stocks are now buying opportunities as Elizabeth Warren climbs in the polls
  • marketwatch.com.10/12 12:26

More

Industry

Biotechnology & Medical Research
-1.17%
Pharmaceuticals & Medical Research
-0.94%

Hot Stocks

Name
Price
%Change

About SAGE

SAGE Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing and commercializing medicines to treat central nervous system (CNS) disorders. The Company's lead product candidate, SAGE-547 is an intravenous formulation of allopregnanolone, a neurosteroid that acts as a synaptic and extrasynaptic modulator of the Gamma-Amino Butyric Acid-A (GABAA) receptor. The Company's next-generation product candidates, SAGE-217 and SAGE-689, also target the GABAA receptor system. The Company is focused on developing drugs based on selective allosteric modulation of CNS synaptic and extrasynaptic receptors. The Company's chemistry platform is focused on the chemical scaffolds of endogenous or chemically modified synthetic neuroactive steroid compounds that are allosteric modulators of GABAA or N-Methyl-D-aspartic acid or N-Methyl-D-aspartate (NMDA) receptors.
More

Webull offers SAGE Therapeutics Inc (SAGE) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.